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The  molecular  components  of  the mitochondrial  Ca2+ uptake  machinery  have  been  only  recently  iden-
tiﬁed.  In the last  months,  in addition  to the  pore  forming  subunit  and  of  one  regulatory  protein  (named
MCU  and  MICU1,  respectively)  other  four components  of this  complex  have  been  described.  In  addition,
a  MCU  KO  mouse  model  has  been  generated  and a genetic  human  disease  due to  missense  mutation  of
MICU1  has  been  discovered.  In this  contribution,  we  will ﬁrst  summarize  the  recent  ﬁndings,  discussingeywords:
itochondrial Ca2+ uniporter
CU
ICU1
ICU2
MRE
the  roles  of  the different  subunits  of the  mitochondrial  Ca2+ uptake  complex,  pointing  to  the  current
contradictions  in  the  published  data,  as  well  as  possible  explanations.  Finally  we will  speculate  on  the
recent,  totally  unexpected,  results  obtained  in  the MCU  knock-out  (KO)  mice.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).CUR
Mitochondria are organelles that form an elaborate network of
ubules and single vesicles within the cytoplasm that are in con-
inuous dynamic equilibrium due to a highly controlled process
f ﬁssion and fusion among themselves. Several aspects of mito-
hondrial functions, from enzyme activity to electron ﬂow in the
espiratory chain, from organelle movement to the release of pro-
poptotic factors are controlled by cytosolic or matrix Ca2+ [1–5].
a2+ homeostasis in mitochondria is controlled by three processes
hat regulate the Ca2+ content within the organelle: (i) the mito-
hondrial Ca2+ uniporter complex (MCUC) for uptake; (ii) Ca2+
uffering in the mitochondrial matrix, due to poorly characterized
atrix protein and by the generation within the matrix of insoluble
Ca2+–xPO4x−–xOH complexes [6]; (iii) Ca2+ extrusion, mediated by
 xNa+/Ca2+ exchanger (mNCX) and a Ca2+/H+ exchanger (mHCX)
3,4,7]. Over the last two years, the proteins involved in the Ca2+
ptake and release processes have been ﬁnally identiﬁed and the
ttention of the researchers is now focused on unravelling their
ynamic interactions and functional regulation (for a recent review
n the topic see [8]).
Over 20 years ago, in a short paper aimed at characterizing
he kinetic characteristics of mitochondrial Ca2+ uptake, one of us
roposed that the mitochondrial Ca2+ uniporter, MCU, was  most
ikely a gated channel [9] rather than a classical carrier, at that
∗ Corresponding author at: Department of Biomedical Sciences, Via G. Colombo 3,
5121 Padova, Italy. Tel.: +39 0498276070.
E-mail address: tullio.pozzan@unipd.it (T. Pozzan).
ttp://dx.doi.org/10.1016/j.ceca.2014.02.008
143-4160/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article untime the prevalent model. The molecular identity of MCU  (and,
accordingly, its channel or carrier nature) remained a mystery until
recently, however. In 2004, Clapham and co-workers, based on
electrophysiological measurements on mitoplasts, conﬁrmed the
original intuition that MCU  is a Ca2+ speciﬁc ion channel [10]. In
2011, the molecular nature of this long searched protein was  ﬁnally
unravelled simultaneously by two independent groups [11,12]. In
less than 2 years the general picture has become far more complex
than anticipated from functional data: in addition to the pore-
forming subunits, named MCU, other proteins have been described
that are capable of modulating the activity, the Ca2+ afﬁnity and
(probably) the assembly of the channel in the mitochondrial mem-
brane. A protein structurally similar to MCU, named MCUb, has
been discovered, that has an inhibitory role on Ca2+ uptake by
the organelles or on Ca2+ current measured in lipid bilayers using
recombinantly expressed MCU  [13]. MICU1, identiﬁed about one
year before MCU  itself [14], was  more recently followed by another
similar protein, MICU2 [15]. Both proteins are located on the outer
surface of the inner mitochondrial membrane where they appear
to modulate the function of MCU  (see below). MCUR1 is another
recently discovered member of the complex, whose deletion results
in abrogation of mitochondrial Ca2+ uptake [16]. The last identiﬁed
member of MCU-associated proteins is named EMRE, and its knock
out completely blocks Ca2+ uptake by mitochondria [17]. The exact
stoichiometry of the different subunits forming MCUC and their
speciﬁc role is still debated (see below), but the present picture
shows the mitochondrial Ca2+ uptake channel as one of the most,
if not the most, sophisticated ion channel described thus far. Such
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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hondrial membrane, IMS: inter membrane space.
omplexity in subunit composition and regulation, maintained and
ncreased during evolution, suggests an essential role of this mito-
hondrial function in cell physiology; indeed mitochondrial Ca2+
ptake has been implicated in the regulation of oxidative phospho-
ylation, modulation of local or general Ca2+ homeostasis, oxygen
adical production and last, but not least, in programmed cell death
for reviews see [4,18–20]). In light of this, the recent paper by
inkel’s group [21] demonstrating that MCU  KO mice are not only
orn normally but that their phenotype is hardly different from
hat of wild type animals was a major surprise for the majority
f experts in the ﬁeld; we will broach this aspect in more detail
elow.
. The molecular nature of the mitochondrial Ca2+
niporter complex, MCUC
The search for the molecular component(s) responsible for mito-
hondrial Ca2+ uptake in energized mitochondria started about 50
ears ago and, until recently, produced only a long list of frus-
rating failures. The keys for identifying such an elusive protein
omplex have been, on the one hand, the novel screening tech-
iques available (genome wide siRNA screening in particular) and,
n the other, the availability of the complete genome sequences
f several eukaryotes that allowed the identiﬁcation of the phylo-
enetic development of the mitochondrial Ca2+ uptake properties.
ssential in the discovery of the ﬁrst members of the mitochondrial
a2+ uptake complex was a rather old, and for a long time neglected,
bservation: the absence of energy-dependent mitochondrial Ca2+
ptake in budding yeast [22].
Based on half a century of experiments and general consensus,he mitochondrial Ca2+ uniporter was predicted: (i) to be expressed
n practically all eukaryotes, but missing in budding yeast; (ii)
o be an integral mitochondrial protein of the inner membrane;
iii) to possess the transmembrane domains necessary to formitochondrial calcium uniporter complex (MCUC) organization. IMM:  inner mito-
an ion channel; (iv) its downregulation or overexpression should
inhibit or increase mitochondrial Ca2+ uptake respectively, without
interfering with the bioenergetic characteristics of the organelle
(membrane potential in particular). The ﬁrst two  proteins identi-
ﬁed by using this type of rationale and suggested to play a role
in Ca2+ uptake by mitochondria were UCP2 and UCP3 [23]. These
proteins belong to a family of H+ channels/transporters (their pro-
totype is UCP1, i.e.,  the protein responsible for the physiological
uncoupling of brown adipose tissue mitochondria [24] (reviewed
in [25]). Neither UCP2 nor UCP3 are expressed in budding yeasts
and Trenker et al. found that, when they were downregulated by
speciﬁc RNAi, a substantial decrease in mitochondrial Ca2+ uptake
occurred; on the contrary, overexpression of UCP2 and 3 increased
the efﬁcacy of mitochondrial Ca2+ accumulation [23]. Neither of
the two  proteins, when expressed in budding yeast, however, con-
ferred to their mitochondria the capacity of accumulating Ca2+ in
the matrix [23], leading the authors to suggest that UCP2 and 3
are modulators of MCU  and not MCU  itself. A large set of experi-
mental data, however, cast doubts on a direct involvement of these
proteins in mitochondrial Ca2+ uptake [26] and their role in this
process remains undeﬁned.
Two years later, using genome-wide siRNA screening, Clapham’s
group reached the conclusion that the protein Letm1 is responsible
for a novel Ca2+ uptake mechanism in mitochondria [27]; in partic-
ular, they suggested that Letm1 is an electrogenic Ca2+/H+ antiport,
distinct from MCU. Downregulation of Letm1 resulted in inhibition
of Ca2+ uptake, but its overexpression hardly affected the process
[27]; most relevant, and in clear contrast with the rationale men-
tioned above, an homologue of Letm1 is present in yeast, named
Yol027/Mdm38, and its KO phenotype can be rescued by expres-
sion of mammalian Letm1 [28]. Their discoverers maintain that
Letm1 is a Ca2+/H+ antiport that insures energy dependent mito-
chondrial Ca2+ uptake at low cytosolic Ca2+ concentrations [29,30],
though in their most recent contribution they conclude that the
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xchange is electroneutral (Ca2+/2H+) and insensitive to Ruthe-
ium Red (and accordingly it should catalyze Ca2+ efﬂux and not
nﬂux). Other groups argued in favour of an indirect role of Letm1 on
a2+ uptake, due to its function as a K+/H+ antiport [31,28,32]. The
ebate and different interpretation of the experimental data is not
ver yet, and this problem will not be further discussed here. The
nterested reader could refer to some recent reviews for additional
nformation on this topic [33].
. MCU  and MICU1
A more convincing candidate component of MCUC was pre-
ented by Mootha’s group with the functional characterization of
ICU1, a protein of the Mitocarta [34] previously named CBARA1
r EFHA3: in their hands, KO of MICU1 abolished mitochondrial
a2+ uptake, though overexpression did not result in a major effect
n the rate and extent of Ca2+ uptake by the organelle [14]. MICU1,
 54-kDa membrane protein, has most, though not all, the other
haracteristics mentioned above for being directly involved in
itochondrial Ca2+ uptake, if not MCU  itself: (i) it is expressed in
ll eukaryotes investigated, but not in budding yeasts; (ii) it is an
ntrinsic inner mitochondrial membrane protein; (iii) it possesses
wo classical EF-hand Ca2+ binding domains [14]. Mootha and
oworkers argued that it was unlikely that MICU1 was the channel-
orming component of MCUC, as MICU1 is predicted to possess
nly one very short membrane-spanning domain, unlike any other
hannel protein described thus far. Indeed, in 2012, Mootha’s and
izzuto’s groups described another protein, now named MCU, that
ad all the characteristics to be the long-searched channel-forming
niporter subunit: it is not expressed in budding yeast, its down-
egulation inhibits and overexpression increases Ca2+ uptake by
itochondria, it is located in the inner membrane and possesses
wo predicted transmembrane -helixes domains. The nuclear
ene encodes a 40-kDa protein, while the mature form of MCU
after cleavage of the N-terminal import domain) is a 35-kDa pro-
ein, devoid of any recognizable Ca2+ binding motif, whose topology
as been a matter of discussion for some time [11,12]: the preva-
ent model today predicts that both its N- and C-terminal domains
ace the mitochondrial matrix, with the two membrane-spanning
omains connected in the intermembrane space by a short loop
ontaining the DIME motif, the most conserved region among MCU
rthologs [11,12]. Recently, employing structural bioinformatics
echniques and molecular dynamics, it has been shown that the
utative pore region of MCU  is deﬁned by eight helices and the neg-
tive electrostatic potential needed for cation permeability is due
o a cluster of negatively charged aminoacids found in the DIME
egion, in proximity of the pore [13]. Importantly, De Stefani et al.
howed that when expressed recombinantly in E. coli or in a wheat
erm extract cell-free system, puriﬁed MCU  forms channels per-
eable to Ca2+ and inhibited by Ruthenium Red, the well-known
locker of mitochondrial Ca2+ uptake in isolated organelles. More-
ver, they showed that a point mutation in the predicted pore
orming domain of MCU  abolishes the current of wt  MCU  in lipid
ilayers and behaves as dominant negative when transfected in
iving cells [11].
It has been argued that the kinetic characteristics of the recon-
tituted channel by puriﬁed MCU  are substantially different from
hose of the Ca2+ current in mitoplasts (IMiCa) [10]. This obser-
ation is not surprising, as MCU  in situ is associated with other
egulatory subunits (see below). Moreover, recent optimization of
he MCU  expression procedures yielded MCU  activity in bilayers
ith kinetics more similar to those of IMiCa [13]. These results
ave been conﬁrmed recently and extended by other groups [35].
o accommodate these ﬁndings, a ﬁrst model was  proposed where
CU, arranged in oligomers, possibly tetramers [13], is postulated 55 (2014) 139–145 141
to be the channel-forming subunits of MCUC, a supercomplex with
a molecular weight around 480 kDa [12].
MCU  and MICU1 physically interact and have a similar tissue
expression pattern [12]. They are both highly conserved during
evolution: indeed, Mootha and co-workers analyzed the distri-
bution of both proteins across 138 fully sequenced eukaryotic
organisms and they found homologs of MCU  distributed widely
across all major branches of eukaryotes, in nearly all metazoan and
plants and in some protozoa. A MCU  homolog is also present in
many fungi, although with signiﬁcant differences in the domain
structure; moreover, fungi mostly lack a MICU1 homolog. A puta-
tive MCU  homolog has been also found in three diverse bacterial
species from the Bacteroidetes/Chlorobi group. Functional stud-
ies are required to determine whether bacterial homologs are also
able to form channels. In that case they would be among the ﬁrst
identiﬁed prokaryotic calcium channels [36].
While there is general agreement on the fact that MCU  repre-
sents the pore forming subunit of MCUC, the role of MICU1  is, on
the contrary, less clear and contradictory data have been published
by different groups. In the original paper on MICU1, Perocchi et al.
showed that MICU1 downregulation results in a potent inhibition
of Ca2+ uptake in both live and digitonin-permeabilized HeLa cells
[14]. These data have been conﬁrmed by Abell et al. in Drosophila
S2 cells [37]. On the contrary, Mallilankaraman and colleagues
have shown that KO of MICU1 leads to an increased mitochon-
drial Ca2+ accumulation at rest, suggesting a role for MICU1 in
establishing a threshold that prevents Ca2+ uptake in basal con-
ditions; they found, however, that it has a marginal effect on the
rate and extent of organelle Ca2+ accumulation upon large cytoso-
lic Ca2+ rises [38]. Csordas et al., on the one hand, conﬁrmed
the suggestion of Mallilankaraman et al. that MICU1  somehow
reduces the Ca2+ afﬁnity of the MCUC at low Ca2+ concentration,
but also found that its downregulation strongly inhibits mitochon-
drial Ca2+ uptake in response to agonist-induced Ca2+ rises [39].
Very recently, Alvarez and coworkers showed that in HeLa cells
silenced for MICU1, the mitochondrial Ca2+ uptake is increased at
cytosolic Ca2+ concentration < 2 M,  while it is decreased at cytoso-
lic Ca2+ concentration > 4 M [40]. Moreover, they observed that at
low cytosolic Ca2+, after a prolonged MCU  opening, an inactivation
mechanism occurs in MICU1 knocked down HeLa cells, indepen-
dently from ROS production and phosphorylation processes [40].
Finally, in a recent paper, Hoffman et al. conﬁrmed that at low
Ca2+ concentrations MICU1 exerts an inhibitory effect on MCU-
dependent Ca2+ uptake, showing that: (i) in HeLa cells expressing
a MICU1 variant (lacking the ability to bind MCU  or mutated in EF-
hand domains, thus acting as a dominant negative), mitochondria
are more effective at buffering cytosolic Ca2+ increases than their
wt counterparts; (ii) mitoplasts from HeLa cells expressing MICU1
lacking the ability to bind MCU  or mutated in EF-hand domains,
exhibit larger MCU  currents (IMCU) compared to wt;  the same result
is obtained in HeLa cells with a stable knockdown of MICU1 [41].
Hoffman et al. also suggested that MICU1 could have pathogenic
role in some forms of cardiovascular diseases (CVD): in particular
in endothelial cells from CVD patients, they showed that MICU1 lev-
els are drastically reduced and that the consequent mitochondrial
Ca2+ phenotype can be reversed by the reintroduction of MICU1
[41].
The reasons for such experimental discrepancies are not entirely
clear yet and our biased opinion is that they may depend in part
on differences in the experimental conditions (buffer composition
and probes for Ca2+ measurement, cell model employed, etc.) and,
possibly more interesting, in a larger complexity of the control of
MCUC functions, for example by protein paralogs of MICU1 (see
below).
No consensus has been reached yet also on the topology of
MICU1 in the inner membrane. Perocchi et al. suggested that the
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argest part of MICU1 faces the intermembrane space [14]; Csordas
t al. [39] conﬁrmed that the two EF-hands of MICU1 are local-
zed on the outer surface of the inner mitochondrial membrane,
nd thus are ideally located to sense the changes in cytosolic Ca2+
oncentration (the outer mitochondrial membrane being freely
ermeable to Ca2+). This topology is thus consistent with the
odels in which MICU1 senses cytosolic Ca2+ and controls the
a2+ afﬁnity of the MCUC. Hoffman et al., on the contrary, con-
luded that MICU1 is compartmentalized primarily in the matrix
ide of the IMM.  Moreover, they also identiﬁed the interaction
omains with MCU, showing that the N-terminal polybasic domain
f MICU1 interacts with the two coiled-coil domains of MCU  and
t is necessary, together with the two EF-hand domains, to exert
he MICU1 effects on MCU  [41]. It is our biased opinion that
he model of Perocchi et al., Csordas et al. and Patron et al. [42]
see below) is better consistent with the available experimental
ata.
. Further complexity in the regulation of mitochondrial
a2+ uptake by MICUs and MCUs paralogs
Our understanding of the complexity of MCUC regulation
ncreased enormously in the last year. Mootha’s group revealed
he expression in most eukaryotic cells of two paralogs of MICU1,
ICU2 (EFHA1) and MICU3 (EFHA2) [15]. The authors suggested
hat these other two genes arose by gene duplication of MICU1, but
hey exhibit a distinct pattern of tissue expression. MICU2 and 3
hare about 25% sequence identity with MICU1 and, similarly to it,
ossess two EF-hands Ca2+ binding sites. MICU2 is a 45-kDa protein
biquitously expressed in mammalian tissues, exclusively localized
n the inner mitochondrial membrane. MICU3 expression seems to
e mostly expressed in the nervous system and up to now it has not
een functionally characterized. On the contrary, an extensive char-
cterization of the role of MICU2 in the process of organelle Ca2+
ccumulation and in the formation of the MCUC has been carried
ut by Mootha and coworkers [15]. In particular, they showed that
n vivo silencing of MICU1 and MICU2 caused an important reduc-
ion in mitochondrial Ca2+ uptake in response to large Ca2+ pulses,
t least in part due to a decreased MCU  expression. They proposed a
eciprocal regulation of MICU1 and 2, that appears to be cell speciﬁc,
s: in HEK293T cells MICU1 siRNA reduces MICU2 protein expres-
ion level (although mRNA levels remain unchanged), but not vice
ersa; in the mouse liver loss of MICU2 results in decreased expres-
ion of MICU1, while MCU  protein levels are reduced by silencing
ICU1, MICU2 and the combination of the two; in HeLa cells, siRNA
gainst one of the MICUs results in the downregulation of the other
soform but it does not affect MCU  levels. Moreover, they demon-
trated that MCU  overexpression increases both the levels of MICU1
nd 2, and MICU1 overexpression increases the levels of MICU2.
inally, they demonstrate that MICU1 and 2 co-precipitate in a
omplex with MCU  [15].
Recently, Rizzuto and coworkers demonstrated that: (i) MICU1
nd MICU2 are localized in the intermembrane space; (ii) MICU1
nd MICU2 heterodimerize in a 95 kDa dimer through the
ormation of a disulphide bond (between MICU1-Cys465 and
ICU2-Cys410); (iii) MICU1 and MICU2 interact with MCU  through
he short DIME loop of MCU  that faces the intermembrane space;
iv) MICU2 exerts an inhibitory effect on MCU  channel activity in
lanar lipid bilayers and in intact HeLa cells; (v) MICU1 shows
 stimulatory effect on MCU  activity in both electrophysiological
nalyses of puriﬁed MCU  inserted in planar lipid bilayers and in
gonist-challenged intact cells; (vi) the protein levels of MICU1 and
 (but not the mRNA) are strongly correlated: the decrease of MICU1
rotein expression decreases also the level of MICU2 and results in
he absence of gatekeeping on MCU  [42]. 55 (2014) 139–145
The model proposed by Rizzuto’s group can be thus summa-
rized: MCU  activity needs a very ﬁne tuning, necessary to prevent
an excess of its activity at resting Ca2+ concentration, to avoid mas-
sive energy dissipation and possibly the triggering of cell death;
an efﬁcient activation mechanism is also necessary to permit fast
Ca2+ uptake when increases in cytosolic Ca2+ are triggered by cell
stimulation. These two essential control mechanisms are provided,
respectively, by MICU2, which exerts its inhibitory activity at low
Ca2+ level, and by MICU1, which plays its activating role dur-
ing cytosolic Ca2+ rises. The authors also showed that MCU  can
immunoprecipitated only with the dimeric form of MICU1  and
2.
It is not easy to rationalize all these data that appear in some
cases clearly contradictory. A possible unifying model that explains
most, but perhaps not all, the experimental ﬁndings described
above is the following: MCUC is composed of at least 3 proteins
that interact with each other: MCU  (that forms the channel), MICU1
and 2 (that regulate the Ca2+ afﬁnity of the channels, MICU2 reduc-
ing and MICU1 increasing the activity). The level of expression of
these three proteins is under reciprocal control that may  vary in
different cell types, though. Accordingly, in some model systems,
downregulation of MICU1 or 2 results not only in a decrease in the
other paralog, but also of MCU, resulting in a net inhibition of Ca2+
uptake; under different conditions or cell type, downregulation of
MICU1 results also in a reduction of MICU2 protein levels, but not
of MCU, leading to a paradoxical activation of Ca2+ uptake at rest
(and possibly its inhibition at higher Ca2+ levels). In conclusion,
the precise roles of MICU1 and 2 remains in part undetermined,
with very complex roles on the afﬁnity of the overall mechanism of
Ca2+ uptake, composition of the MCUC, and regulation at the gene
expression level and protein stability.
Not only does MICU1 have paralogs, but also a similar situ-
ation appears to be true for MCU; in particular, Raffaello et al.
have recently demonstrated the existence of an isoform of MCU
(CCDC109B), named MCUb, whose primary sequence is 50% homol-
ogous to that of MCU, but with key mutations in the predicted pore
forming region [13]. MCUb is a 35-kDa protein with two trans-
membrane domains, encoded by a gene located on Homo sapiens
chromosome 4. Rather than an isoform of MCU, MCUb appears
to be a subunit of the complex with inhibitory characteristics: its
overexpression in intact cells reduces Ca2+ uptake of mitochon-
dria in response to cytosolic Ca2+ increases, while in lipid bilayers
the coexpression of MCU  and MCUb dramatically inhibits the Ca2+
current due to MCU  alone [13]. Similarly to MICU2, also the expres-
sion of MCUb is quite variable in mouse tissues, and in general
lower than that of MCU. Concerning mRNA levels, MCUb tran-
script is abundant in heart and lung, while it is scarce in skeletal
muscle, and it is in general lower than MCU. As a consequence,
the ratio MCU/MCUb varies in different tissues and this variabil-
ity seems not correlated to MCU  expression levels. These data are
also conﬁrmed in terms of Ca2+ uptake efﬁcacy that is greater in
skeletal muscle than in heart [43]. Structurally, the main differences
between MCU  and MCUb concern the DIME domain. In particular
an E256V substitution makes MCUb less electronegative than MCU
and that could affect the kinetics of Ca2+ permeability. Moreover,
substitution in MCU  of the two aminoacids R251 and D256 of the
putative pore-forming domain with the corresponding aminoacids
of MCUb (W and V, respectively) results in the inhibition of the Ca2+
channel activity of MCU, both when expressed in living cells or in
reconstituted lipid bilayer experiments [13]. The existence of an
endogenous negative modulator of MCU, however, offers a poten-
tially unprecedented mechanism for regulating the activity of an
ion channel through the expression of a physiological dominant
negative subunit. MCUb can be co-immunoprecipitated with MCU
[17]; this information, together with the data about the physical
interaction between MCU  and MICU1 and 2 suggests the existence
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f an heteromeric complex containing all these proteins, though
heir relative stoichiometry is presently unknown.
. More subunits of the MCUC
If all that has been discussed above were not complex enough,
n the last few months two other proteins have been discovered
hat appear to be strongly associated with the Ca2+ transporting
omplex made by MICUs and MCUs, i.e.,  MCUR1 [16] and EMRE
17]. MCUR1 (Mitochondrial Ca2+ Unipoter Regulator 1, also named
CDC90A) was identiﬁed by using siRNA screening in HEK293T.
t is a 40-kDa protein with two transmembrane domains and one
oiled-coil region. The N- and C-terminus face the intermembrane
pace, while the major part of the protein is exposed to the matrix.
he striking phenotype of cells deprived of MCUR1 is the lack
f any energy dependent Ca2+ uptake, without effects on mito-
hondrial membrane potential. Cells deprived of MCUR1 present
everal bioenergetics defects typical of a block of mitochondrial
a2+ uptake, such as increase autophagy and reduced sensitivity
o apoptosis [16]. The authors showed that MCUR1 coprecipitates
ith MCU, but not with MICU1, and that its overexpression results
n an increase of mitochondrial Ca2+ uptake, but only when MCU  is
xpressed. MCUR1 appears also to regulate the expression of MCU,
s downregulation of MCUR1 results in a signiﬁcant increase of both
he mRNA and the protein levels of MCU. Although MCUR1 pos-
esses two predicted transmembrane domains, no evidence was
btained in support of its channel forming activity, suggesting that
CUR1 affects either the opening of MCU  or the assembly of the
omplex or both. Most relevant, however, an MCUR1 analogue is
xpressed in budding yeast, named FMP32 [44], unlike what is pre-
icted for proteins speciﬁcally involved in the regulation of Ca2+
ptake by mitochondria. Accordingly, one would be tempted to
peculate that MCUR1 is not a speciﬁc regulator of MCUC, but has
dditional important functions (yet unknown) in the organelles
hat are independent of its effects on Ca2+ uptake.
The most recently discovered member of the mitochondrial
niport complex subunits is the protein called EMRE (Essential
CU REgulator) or C22ORF32. EMRE was identiﬁed by quanti-
ative mass spectrometry (SILAC) as a component of a high MW
omplex of inner mitochondrial membrane isolated by blue native
lectrophoresis after immunoprecipitating MCU  [17]. EMRE is a
0-kDa single-pass membrane protein with a highly conserved
-terminus and enriched in aspartate. In the isolated complex,
CUs and MICUs are found together with EMRE, while MCUR1 was
ot co-immunoprecipitated with the other proteins. In particular,
MRE has been shown to interact with MCU  at the IMM  and with
ICU1 in the intermembrane space, possibly acting as a bridge
etween MCU  and MICUs. Furthermore, the authors demonstrate
hat EMRE is necessary for the association of MCU  with MICU1/2,
ince, in absence of EMRE, MCU  can still co-precipitate with MCUb,
ICU1 and 2 can dimerize, while MCU  cannot co-precipitate with
ICU1/2 [17]. The reason for the discrepancy in relation to the
ata of Mallilankaraman et al., who could co-immunoprecipitate
CUR1 with MCU  [16], and the latter data on EMRE is presently
nknown. No EMRE homologs exist in plants, fungi or protozoa
uggesting that it most likely arose in the metazoan lineage. As far
s EMRE mRNA expression is concerned, it was  found in all mouse
issues and is predicted to be broadly expressed in mammalian
issues. Downregulation of EMRE results in complete inhibition
f energy dependent Ca2+ uptake in intact cells and isolated
rganelles; moreover, overexpression of MCU  in cells silenced for
MRE does not allow the recovery of mitochondrial Ca2+ uptake.
MRE thus appears to be a necessary regulator, similar to MCUR1,
f the MCU  transport, rather than a pore-forming unit; in addition,
s EMRE is not expressed in plants and given that MCU  per se (either 55 (2014) 139–145 143
expressed in E. coli or synthetized in vitro and inserted in lipid
bilayers) results in Ca2+ permeable channel [11], a conservative
interpretation of these apparently contradictory data is that EMRE
is involved in the assembly of the Ca2+ uptake machinery in the
inner mitochondrial membrane of mammalian cells. This is, for
the time being, a pure speculation, but the hypothesis is clearly
experimentally testable.The contributions by Mallilankaraman
et al. on MCUR1 and of Sancak et al. on EMRE are the ﬁrst, and thus
far the only, studies on the role of these proteins on Ca2+ uptake by
mitochondria. Thus, the impact of these observations on the overall
control mechanism of the process awaits further and more detailed
studies. Despite this caveat, taken together, the data indicate that
Ca2+ import in mitochondria involves an extremely complex
molecular machinery, highly conserved in its basic features with
regulatory mechanisms that were added during evolution (Fig. 1)
Together with the enormous set of data indicating the involvement
of mitochondrial Ca2+ uptake in many key aspect of cell physiology
and pathology (from Ca2+ buffering to modulation of metabolism,
from control of specialized functions to the control of apoptotic
or necrotic cell death), it was  almost obvious to anticipate that
functional KO of MCU  would result in an embryonically lethal phe-
notype.Indeed, dramatic phenotypes have been obtained in studies
carried out knocking down MCU  in zebraﬁsh [45] or in the protist
Trypanosoma brucei.  (Ref: Essential regulation of cell bioenergetics
in Trypanosoma brucei by the mitochondrial calcium uniporter,
Nat Commun. (2013) 4:2865. doi: 10.1038/ncomms3865)[45].
5. The paradox of the MCU  KO mouse
The paper by Finkel and co-workers, published a few weeks
ago, came as a shocking result for most students in the ﬁeld: MCU
KO mice obtained using the gene trap technique are not only reg-
ularly born, but their phenotype is very mild: the animals are
slightly smaller than their wild type littermates and they have
modest defects in skeletal muscle strength and some alterations of
metabolic functions (in particular in the control of pyruvate dehy-
drogenase) [21]. Thus, while in less developed animals MCU  plays
a non-dispensable role, this appears not to be the case in more
complex animal species such as the mouse. The obvious explana-
tion, i.e.,  the existence in mammals of alternative pathways for Ca2+
uptake in mitochondria does not appear to be easily tenable (see
also below), based on the published data: mitochondria isolated
from both skeletal and cardiac muscles of MCU  KO mice are totally
incapable of accumulating Ca2+ in an energy dependent way and in
MEFs from the same transgenic mice Ca2+ mobilization from intra-
cellular stores results in no detectable increase in mitochondrial
Ca2+ levels [21]. Surprisingly, Pan et al. found that the Ca2+ content
in mitochondria of MCU  KO cells is only partially reduced compared
to that in wild type animals. The authors themselves thus hypothe-
sized the existence of alternative Ca2+ uptake pathways, capable of
catalyzing only a slow Ca2+ accumulation, though [21]. The nature
of this (these) pathway(s), if any, remains unknown. On the exis-
tence of alternative mitochondrial Ca2+ uptake pathways of interest
are the recent observations by Graier and co-workers. In one of
these studies they argued that, depending on the cell type and the
methodology employed, up to 5 different Ca2+ currents can be iden-
tiﬁed in mitoplasts by electrophysiology (see [46]). In a more recent
study, the same group investigated, using the patch clamp tech-
nique, the inward cation currents and single Ca2+ channel activities
in mitoplasts from stable MCU  knockdown HeLa cells [47]. Reduc-
tion of MCU  levels resulted in a strong reduction in the frequency
of single Ca2+ channel activity in patched mitoplasts (they named
this current i-MCC). However, ablation of MCU  resulted in a strong
elevation of a high conductance mitochondrial Ca2+ current (that
they named xl-MCC). They suggested the existence in mitochondria
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f at least two different Ca2+ channels, one MCU  dependent (and
esponsible for the i-MCC current) and another, MCU-independent.
s much as the existence of multiple mitochondrial Ca2+ inﬂux
athways is fascinating (and could explain the mild phenotype of
CU  KO mice), it needs stressing that, in MCU  KO animals, either
n isolated organelles or in living cells, Pan et al. did not found any
vidence for energy dependent Ca2+ uptake.
Pan et al. also showed that the cardiac infarct size (caused by
0 min  of no-ﬂow global ischaemia) in wild type and MCU  KO
nimals is indistinguishable, but differently sensitive to the per-
eability transition pore (PTP) inhibitor Cyclosporin A (CsA): the
O animals are totally insensitive to the drug, while the wild type
re strongly protected by the same treatment [21]. The latter exper-
ment is of special relevance as it conﬁrms that the effects of CsA
n ischaemic death of cardiac cells is directly related to the inhibi-
ion by the drug of Ca2+ activated Permeability Transition Pore, PTP,
pening. Most relevant for what discussed here, the data indicate
hat the default death pathway caused by ischaemia in wild type
earts is to a large extent mediated by Ca2+-activated PTP opening,
ut an alternative death pathway can be activated if mitochon-
rial Ca2+ accumulation is genetically blocked. No information is
et available on whether the wt and KO mice have the very same
ensitivity to ischaemic death, for example whether the extent of
he infarcted zone is affected by MCU  KO using different protocols
e.g., duration of the ischaemic protocol, sensitivity to O2-radical
roduction, etc.) or whether the death of cardiac cells in MCU  KO is
rimarily due to necrosis rather than apoptosis. As far as PTP and
ell death are concerned, it needs stressing that, as clearly demon-
trated by Bernardi et al., the inhibitory effect of CsA on PTP opening
s not a generic effect on the activation of that channel, but rather
t is due to the CsA-dependent reduced sensitivity of PTP to Ca2+-
ependent opening [48]. In other words, the lack of CsA effect does
ot exclude the involvement of PTP in the death of cardiac myocytes
f KO animals (as the PTP may  be opened by other mechanisms
elated to ischaemia), but conﬁrms that the default pathway of
schaemia-dependent cell death in the hearts of wild type animals
s mediated through MCU  and Ca2+ activation of PTP. What other
athway might so efﬁciently compensate the lack of MCU  remains
otally unexplained. Along the same line of reasoning, it is quite
emarkable that the embryonic development of all organs, requir-
ng massive apoptosis to reach completion, is essentially unaffected
n the MCU  KO mice. Plenty of evidence, obtained both in vitro and
n vivo, suggests that apoptosis is highly dependent on mitochon-
rial Ca2+ accumulation and PTP opening. Again, as suggested above
or ischaemic cell death, one may  postulate that normal embryo-
enesis takes advantage of the classical, Ca2+- and PTP-dependent,
athway, while mammals have developed alternative signals that
an efﬁciently substitute the default mechanism, if necessary.
lternatively, one must assume that the MCU-dependent mech-
nism is either irrelevant or easily dispensable for programmed
ell death activation in mammalian embryos. A last, but at present
otally speculative hypothesis, would be the existence of embryo
peciﬁc spliced variants of MCU  that bypass the stop codon inserted
n the ﬁrst intron (the strategy used to generate the KO mouse of
inkel and coworkers). Spliced variants of MCU  are indeed pre-
icted, but whether or not they actually result in functional proteins
nd, more important, whether the stop codon could be bypassed
y the splicing mechanism is presently unknown. In addition, this
ypothesis is contradicted by the total lack of fast Ca2+ uptake in
EF  from MCU  KO animals. Admittedly, MEFs are cells cultured
n vitro and the possibility that they loose the embryonic MCU
pliced variants, if they exist, cannot be excluded. The last surpris-
ng ﬁnding of the MCU  KO mouse is that live KO mice were obtained
nly in a mixed genetic background of C57BL/6 and CD1, while the
bsence of mitochondrial Ca2+ uptake appears to be embryonically
ethal in a pure background (unpublished observations). 55 (2014) 139–145
Clearly, the very mild phenotype of MCU  KO mice was  totally
unexpected for most investigators in the ﬁeld. However, before
playing a requiem for the relevance of MCU  in cell physiology and
pathology of mammals, more information needs however to be
obtained. Among them: (i) tissue speciﬁc and inducible KO animals
must be generated and thoroughly investigated; (ii) the mystery
of the genetic background difference needs to be explained; (iii)
the existence of alternative Ca2+ inﬂux pathways must be further
investigated. It is however rather surprising and evolutionary con-
tradictory that a highly sophisticated gated channel such as the
mitochondrial Ca2+ inﬂux mechanism, with at least 6 different
subunits controlling its activity and assembly (not to mention an
isoform speciﬁc mitochondrial subunit of the Na+/Ca2+ exchanger),
would turn out to be a key property of mitochondria of lower
eukaryotes and almost completely dispensable in mammals. An
additional, and most important caveat, in downgrading the MCUC
to a dispensable complex in mammals comes from the recent iden-
tiﬁcation of a genetic human disease, in which mutations of MICU1
were associated with proximal myopathy, learning difﬁculties and
a progressive extrapyramidal movement disorder [49]. Evidence
has been provided indicating that the phenotype of the patients is
caused by a primary defect in mitochondrial Ca2+ signalling, argu-
ing for a critical role of mitochondrial Ca2+ uptake in several human
tissues.
It is worth mentioning that MCU  is not the sole example in the
recent literature where the KO in mice of genes that were believed
to be essential turned out to be devoid of phenotype (or with a
very mild one). Just to name a few: KO of creatine kinase [50] or
interleukin-1a/b double knock out [51] induced no obvious pheno-
type in mice. Strikingly, myoglobin KO mice were created in 1998
[52] and they too showed no obvious phenotype. In the years that
followed, several compensatory mechanisms that include increases
in cardiac capillary density, coronary ﬂow, haemoglobin, changes
in fatty acid metabolism and resistance to hypoxic stress [53–58]
were reported. One is tempted to conclude that, on the one hand,
the compensating capabilities to the lack of a single gene are far
more efﬁcient than we had anticipated, on the other that the func-
tional phenotyping presently employed are still too simpliﬁed to
reveal the importance of a protein or of a signalling pathway. It is
thus easy to predict that the next few years will be full of surpris-
ing ﬁndings in the ﬁeld of mitochondrial Ca2+ homeostasis. This
topic, for many years investigated primarily with phenomenologi-
cal approaches, is now based on strong molecular and genetic basis
and we  are looking forward to a fascinating future.
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